Invention Grant
- Patent Title: Tumor biomarker
- Patent Title (中): 肿瘤生物标志物
-
Application No.: US12880265Application Date: 2010-09-13
-
Publication No.: US08389684B2Publication Date: 2013-03-05
- Inventor: Yongzhang Luo , Xiaomin Song , Xiaofeng Wang , Wei Zhuo , Guodong Chang , Yan Fu
- Applicant: Yongzhang Luo , Xiaomin Song , Xiaofeng Wang , Wei Zhuo , Guodong Chang , Yan Fu
- Applicant Address: CN Beijing CN Beijing
- Assignee: Tsinghua University,Protgen Ltd.
- Current Assignee: Tsinghua University,Protgen Ltd.
- Current Assignee Address: CN Beijing CN Beijing
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Main IPC: C07K1/00
- IPC: C07K1/00 ; C07K14/00 ; C07K17/00 ; G01N33/00
Abstract:
The present invention relates to the diagnosis and treatment of cancer, and specifically to a method of diagnosing the presence or metastasis of cancer by detecting plasma Hsp90α having the amino acid sequence of SEQ ID No. 1 as a tumor marker. In addition, the present invention also relates to a method for the treatment of cancer and metastasis.
Public/Granted literature
- US20120064078A1 Novel Tumor Biomarket Public/Granted day:2012-03-15
Information query
